A cost-effectiveness model for coronary thrombolysis/reperfusion therapy.

[1]  P. Serruys,et al.  Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? , 1986, Circulation.

[2]  R. Erbel,et al.  Percutaneous transluminal coronary angioplasty after thrombolytic therapy: a prospective controlled randomized trial. , 1986, Journal of the American College of Cardiology.

[3]  H. Drexler,et al.  Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex. , 1986, The American journal of cardiology.

[4]  Y. Ohtsuki,et al.  ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.

[5]  E. Braunwald,et al.  Management of the residual stenosis following thrombolytic therapy of acute myocardial infarction. , 1986, Cardiology.

[6]  R. W. Brower,et al.  Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction. , 1986, Journal of the American College of Cardiology.

[7]  G. Taylor,et al.  Thrombolytic therapy followed by early revascularization for acute myocardial infarction. , 1986, The American journal of cardiology.

[8]  J. Alpert,et al.  Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. , 1986, JAMA.

[9]  P. Serruys,et al.  Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. , 1986, Journal of the American College of Cardiology.

[10]  P. Serruys,et al.  Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction. , 1986, Journal of the American College of Cardiology.

[11]  B. Pitt,et al.  A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. , 1986, The New England journal of medicine.

[12]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico..  EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.

[13]  I. Palacios,et al.  Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.

[14]  E. Braunwald,et al.  Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. , 1986, Circulation.

[15]  C. G. Blomqvist,et al.  Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. , 1986, New England Journal of Medicine.

[16]  T. Drake.  Coronary thrombolysis with recombinant tissue-type plasminogen activator , 1986 .

[17]  J. Spann,et al.  Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction. , 1986, The American journal of cardiology.

[18]  M. Gotsman,et al.  Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. , 1985, The New England journal of medicine.

[19]  E. Braunwald,et al.  High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial. , 1985, Journal of the American College of Cardiology.

[20]  J. Douglas,et al.  In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. , 1985, Circulation.

[21]  E. Gilpin,et al.  Survival after hospital discharge in matched populations with inferior or anterior myocardial infarction. , 1985, Journal of the American College of Cardiology.

[22]  D. McKee,et al.  Life adaptation after percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. , 1985, The American journal of cardiology.

[23]  F. Sheehan,et al.  Time from onset of symptoms to thrombolytic therapy: a major determinant of myocardial salvage in patients with acute transmural infarction. , 1985, Journal of the American College of Cardiology.

[24]  E. Braunwald.  The aggressive treatment of acute myocardial infarction. , 1985, Circulation.

[25]  F. Sheehan,et al.  Factors that determine recovery of left ventricular function after thrombolysis in patients with acute myocardial infarction. , 1985, Circulation.

[26]  J L Ritchie,et al.  The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report. , 1985, The New England journal of medicine.

[27]  M. Verani,et al.  Intracoronary thrombolytic therapy in acute myocardial infarction: a prospective, randomized, controlled trial. , 1985, The American journal of cardiology.

[28]  J. Arciniegas,et al.  Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction. , 1985, The American journal of cardiology.

[29]  K. Karsch,et al.  Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. , 1984, The New England journal of medicine.

[30]  B E Sobel,et al.  Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial. , 1984, Circulation.

[31]  J. Anderson,et al.  Long-term follow-up after intracoronary streptokinase for myocardial infarction: a randomized, controlled study. , 1984, American heart journal.

[32]  P. Mcmaster,et al.  Left ventricular dysfunction after acute myocardial infarction: results of a prospective multicenter study. , 1984, Journal of the American College of Cardiology.

[33]  S. M. Collins,et al.  Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. , 1984, Circulation.

[34]  C. White,et al.  Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? , 1984, The New England journal of medicine.

[35]  R. Schröder.  Intravenous short-term infusion of streptokinase in acute myocardial infarction. , 1984, International journal of cardiology.

[36]  A. Ross,et al.  A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. , 1984, The American journal of cardiology.

[37]  B. Rutherford,et al.  Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. , 1983, American heart journal.

[38]  C. J. Kooijman,et al.  Is transluminal coronary angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study. , 1983, British heart journal.

[39]  J. Fleiss,et al.  Risk stratification and survival after myocardial infarction. , 1983, The New England journal of medicine.

[40]  I. Palacios,et al.  Coronary reocclusion after selective administration of streptokinase. , 1983, Circulation.

[41]  D. Berman,et al.  Nonsurgical reperfusion in evolving myocardial infarction. , 1983, Journal of the American College of Cardiology.

[42]  K. Wegscheider,et al.  Intravenous Short‐term Infusion of Streptokinase in Acute Myocardial Infarction , 1983, Circulation.

[43]  A. Maurer,et al.  High-dose, brief intravenous streptokinase early in acute myocardial infarction. , 1982, American heart journal.

[44]  P. Rentrop,et al.  Intracoronary streptokinase thrombolytic recanalization and subsequent surgical bypass of remaining atherosclerotic stenosis in acute myocardial infarction: complementary combined approach effecting reduced infarct size, preventing reinfarction, and improving left ventricular function. , 1981, American heart journal.

[45]  S. D. Roberts,et al.  Cost-effective care of end-stage renal disease: a billion dollar question. , 1980, Annals of internal medicine.

[46]  M. Weinstein,et al.  Allocation of Resources to Manage Hypertension , 1977 .

[47]  S Cretin,et al.  Cost/benefit analysis of treatment and prevention of myocardial infarction. , 1977, Health services research.